Publication date: Jul 01, 2024
mRNA vaccines have been a critical tool in combating the current coronavirus disease 2019 (COVID-19) pandemic and demonstrated a high safety profile. However, rare cases of isolated oculomotor nerve palsy following vaccination have been reported. These few reported cases can be divided into two groups based on symptom onset: immediate and delayed. While most reported cases involving Pfizer and Moderna vaccines occurred within the first few days of vaccination, a few cases with delayed onset have also been described. We present a unique case of a patient experiencing isolated, unilateral oculomotor nerve palsy 14 days after receiving a Moderna booster shot. Notably, our case and a previously reported case of 17-day onset case share the interesting finding of positive ganglioside antibodies. This not only highlights the potential for unusual occurrences following COVID-19 vaccination but also opens up avenues for exploring the underlying mechanisms behind these events.
Concepts | Keywords |
---|---|
Antibodies | asialo-gm1 antibody |
Coronavirus | covid-19 |
Covid | moderna |
Moderna | pfizer |
Rare |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Oculomotor Nerve Palsy |
disease | VO | vaccination |
disease | MESH | coronavirus disease 2019 |
disease | IDO | symptom |